论文部分内容阅读
本文分析了我国药品流通中存在的三种“逆价格”现象及其现实成因,即药品严重供过于求的结果不是价格下降,而是价格上升;在药效基本相同的条件下,价格越贵的药反而越好销售;供不应求的药品,价格反而越便宜。文章认为,政府垄断与经营垄断糅合,信息不对称和交易地位不对称规制的失效是“逆价格”产生的内在根源;治理“逆价格”一要破除药品销售中的行政垄断与经营垄断;二要加大监管力度,改进监管方法;三要放开市场竞争。
This article analyzes the three kinds of “reverse prices” in the circulation of pharmaceuticals in our country and its realistic causes. That is, the serious oversupply of pharmaceuticals results not in price reduction, but in price. Under the same basic pharmacological effects, the more expensive drugs But the better sales; in short supply of medicines, the cheaper the price instead. The article holds that the combination of government monopoly and management monopoly, the asymmetric information and the invalidation of asymmetric transaction status are the intrinsic causes of “reverse price”; the “reverse price” is to eliminate the administrative monopoly and operating monopoly in drug sales; We should step up supervision and improve supervision methods. Third, we must let go of market competition.